Halozyme Therapeutics Presents Pre-Clinical Studies On Dermal Remodeling With HTI-501, A Lysosomal Proteinase

Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix ("Matrix"), announced the presentation of new pre-clinical findings on the controlled modification of the Matrix with HTI-501 at the European Society for Dermatological Research (ESDR) and Japanese Society for Investigative Dermatology (JSID).

Dermatologists Link Family History To Shingles Susceptibility

Researchers at The University of Texas Medical School at Houston have identified family history as one reason why some people might be more susceptible to shingles, a severe skin condition. Their findings are published in the May 19 issue of Archives of Dermatology.

How To Protect Your Child's Skin From The Sun - NewYork-Presbyterian Hospital Dermatologists Offer Tips

It's never too late to take precautions against skin cancer. The incidence of melanoma, a potentially fatal skin cancer, is increasing dramatically. It is currently the most common type of cancer in women between the ages of 25 and 29. "Sun exposure plays a significant role in the development of melanoma.

A Loving Partner Can Save Your Skin

Even couples that have been together for years may be embarrassed to let a spouse or partner see their less than perfect bodies naked in bright light. That shyness can hamper a couple's willingness to do total body skin exams on each other to check for a new or recurring melanoma.

FDA Clears Spectra VRM III Q-Switched ND, Lag Laser System For Treating A Broad Spectrum Of Dermatological And Aesthetic Conditions

Lutronic, one of the world's leading developers and manufacturers of medical laser systems, announced today that it has received FDA clearance to market its Spectra VRM III multiple laser wavelength system. This dual pulse Q-Switched Nd: Yag laser is the feature-laden successor to the Spectra VRM II.

Helpful Hints To Get Your Feet Ready For The Summer Season

A winter of wearing tight-fitting shoes or boots can wreak havoc on your feet and make you think twice before putting on scanty sandals or going barefoot. "Unlike the rest of the body, people seem to neglect their feet throughout most of the year and, therefore, can encounter a host of problems that become compounded once the summer arrives, " says Dr.

Genome-Wide Study Rapidly Scans DNA For Clues, Narrows Search For New Melanoma Gene

It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Despite years of research and clinical development, melanoma incidences continue to rise around the world.

The Starting Point Of Sun-Induced Skin Cancer Disovered By U Of Minnesota Researcher

According to a new study from the University of Minnesota, the earliest event in the development of sun-induced skin cancer may have been identified. The researchers found that the point of entry for skin cancer in response to sun exposure is in receptor molecules, molecular "hooks" on the outer surface of cells that also pull cannabinoid compounds found in marijuana out of the bloodstream.

Efalizumab Raptiva Is Safe For Long-Term Use In Psoriasis Patients

A review of data based on ten years of experience using efalizumab (Raptiva ) to treat chronic plaque psoriasis confirms that that the drug has a favorable long-term safety profile. The chronic plaque form of psoriasis accounts for about 75 percent of psoriasis cases.

Researchers Show Ustekinumab For Psoriasis Is Effective

Research published in two articles in this week's The Lancethas demonstrated that moderate-to-severe psoriasis can be effectivelytreated with the drug ustekinumab. In these PHOENIX trials, the authorshave also shown that treatment every 12 weeks maintains efficacy inmost people.